Paul Tudor Jones Shockwave Medical, Inc. Call Options Transaction History

Tudor Investment Corp Et Al

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$191.17 - $325.63 $133,819 - $227,941	700 New	700 $227,000
Q3 2023 Nov 15, 2023	BUY	$194.33 - $283.97 $291,495 - $425,955	1,500 Added 62.5%	3,900 $776,000
Q1 2023 May 15, 2023	SELL	$175.41 - $217.92 $17,541 - $21,792	-100 Reduced 4.0%	2,400 $521,000
Q4 2022 Feb 14, 2023	BUY	$204.38 - $296.82 $306,570 - $445,230	1,500 Added 150.0%	2,500 $514,000
Q3 2022 Nov 14, 2022	BUY	$195.21 - $310.53 $195,210 - $310,530	1,000 New	1,000 $278,000
Q1 2022 May 16, 2022	SELL	$127.96 - $207.36 $383,880 - $622,080	-3,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$165.13 - $241.83 $495,390 - $725,490	3,000 New	3,000 $536,000

321K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.